Patents by Inventor Fang Mel

Fang Mel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of tumor susceptibilty gene 101 (TSG 101) as a prognostic and diagnostic marker
    Patent number: 7897340
    Abstract: The present invention discloses the link between oncogenic Ras and TSG101 and the negative effect of TSG101 on the expression of p21 in ovarian cancer. The present also discloses the use of TSG101 as a prognostic, diagnostic marker and a potential therapeutic target in cancer, especially ovarian cancer.
    Type: Grant
    Filed: February 13, 2007
    Date of Patent: March 1, 2011
    Assignee: The Board of Regents of the University of Texas System
    Inventors: Xiaodong Cheng, Fang Mel, Travis Young, Jinsong Liu
  • Use of tumor susceptibilty gene 101 (TSG 101) as a prognostic and diagnostic marker
    Publication number: 20070243547
    Abstract: The present invention discloses the link between oncogenic Ras and TSG101 and the negative effect of TSG101 on the expression of p21 in ovarian cancer. The present also discloses the use of TSG101 as a prognostic, diagnostic marker and a potential therapeutic target in cancer, especially ovarian cancer.
    Type: Application
    Filed: February 13, 2007
    Publication date: October 18, 2007
    Inventors: Xiaodong Cheng, Fang Mel, Travis Young, Jinsong Liu